88 related articles for article (PubMed ID: 6346417)
1. [Evaluation of residual functional beta-cell response in childhood and juvenile diabetes in relation to early diagnosis and to the forms of onset of the disease].
Campea L; Raponi MP; Trotta MR; Costantino F; Davi G; Orsini M
Recenti Prog Med; 1983 Jan; 74(1):36-52. PubMed ID: 6346417
[No Abstract] [Full Text] [Related]
2. [beta-Cell residual function in juvenile diabetes mellitus (author's transl)].
Schober E; Schernthaner G; Frisch H
Monatsschr Kinderheilkd; 1980 Dec; 128(12):776-9. PubMed ID: 6109242
[TBL] [Abstract][Full Text] [Related]
3. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
4. [Clinical heterogeneity of childhood diabetes in Baranya county].
Makovi H; Soltész G; Hermann R
Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
[TBL] [Abstract][Full Text] [Related]
5. Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.
Pitocco D; DiStasio E; Crinò A; Manfrini S; Guglielmi C; Visalli N; Suraci C; Matteoli MC; Cavallo MG; Bizzarri C; Pozzilli P;
Horm Metab Res; 2008 Jan; 40(1):66-8. PubMed ID: 18085501
[No Abstract] [Full Text] [Related]
6. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.
Madsbad S
Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267
[No Abstract] [Full Text] [Related]
7. Beta-cell function assessed by plasma C-peptide evaluation in diabetic thalassaemic patients.
Atti G; Capra L; De Sanctis V; Vullo C; Bagni B
Helv Paediatr Acta; 1983 May; 38(2):123-32. PubMed ID: 6347976
[TBL] [Abstract][Full Text] [Related]
8. Beta cell function. Restoration and preservation of B-cells in children with type I diabetes.
Jackson RL; Bilginturan NA; Terry CW; Hewett JE
J Kans Med Soc; 1983 Jun; 84(6):321-30, 353. PubMed ID: 6348187
[No Abstract] [Full Text] [Related]
9. Evaluation of the beta cell response by C-peptide measurement in parents of children with type I diabetes.
Snehalatha C; Ramachandran A; Satyavani K; Sivasankari S; Nanditha R; Vijay V; Hitman GA
J Assoc Physicians India; 2003 Sep; 51():927-8. PubMed ID: 14710988
[No Abstract] [Full Text] [Related]
10. Restoring a functional beta-cell mass in diabetes.
Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
[TBL] [Abstract][Full Text] [Related]
11. Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?
Kolb H; Gale EA
Diabetologia; 2001 Oct; 44(10):1349-53. PubMed ID: 11692186
[TBL] [Abstract][Full Text] [Related]
12. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
13. [Function of the islands of Langerhans and the course of diabetes mellitus in children].
Kniazev IuA; Vakhrusheva LL; Demidova LV; Kuznetsova NN
Pediatriia; 1981 Oct; (10):10-2. PubMed ID: 7031587
[No Abstract] [Full Text] [Related]
14. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
[No Abstract] [Full Text] [Related]
15. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
Schober E; Schernthaner G; Frisch H; Fink M
J Endocrinol Invest; 1984 Oct; 7(5):507-12. PubMed ID: 6392401
[TBL] [Abstract][Full Text] [Related]
17. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell secretory function and CD25 + lymphocyte subsets in the early stage of type 1 diabetes mellitus.
Milicevic Z; Knezevic J; Sabioncello A; Roglic G; Rocic B
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):181-6. PubMed ID: 15127321
[TBL] [Abstract][Full Text] [Related]
19. [Importance of plasma C-peptide evaluation during the oral glucose tolerance test in infantile and juvenile obesity].
Marincola G; Cogliati F; Mauri R; Atterrato A; Resentini M
Minerva Pediatr; 1983 Jan; 35(1-2):77. PubMed ID: 6835186
[No Abstract] [Full Text] [Related]
20. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.
Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I
Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
